Effect of a fermented milk containing Bifidobacterium animalis DN‐173 010 on the health‐related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double‐blind, controlled trial

• Published in: Alimentary Pharmacology and Therapeutics Vol. 26; no. 3; pp. 475 - 486
• Main Authors: GUYONNET, D., CHASSANY, O., DUCROTTE, P., PICARD, C., MOURET, M., MERCIER, C.‐H., MATUCHANSKY, C.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.08.2007; Blackwell; Wiley
• Subjects: Adolescent; Adult; Aged; Bifidobacteriales Infections - microbiology; Bifidobacteriales Infections - therapy; Bifidobacterium; Bifidobacterium animalis; Biological and medical sciences; Digestive system; domain_sdv.mp.prb; domain_sdv.mp.prb.bif; Double-Blind Method; Female; Gastroenterology. Liver. Pancreas. Abdomen; Humans; Irritable Bowel Syndrome - microbiology; Irritable Bowel Syndrome - therapy; Life Sciences; Male; Medical sciences; Microbiology and Parasitology; Middle Aged; Other diseases. Semiology; Pharmacology. Drug treatments; Primary Health Care; Probiotics - therapeutic use; Quality of Life; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus; Treatment Outcome; Yogurt - microbiology; Human; Bifidobacterium; Actinomycetaceae; Primary health care; Health-Related Quality of Life; Actinomycetales; Symptomatology; Randomization; Irritable bowel syndrome; Double blind study; Digestive diseases; Bacteria; Intestinal disease; Adult; Clinical trial; Actinomycetes; Milk

Summary Background  Health‐related quality of life (HRQoL) has been rarely evaluated as a primary endpoint in the assessment of the effect of probiotics on the irritable bowel syndrome (IBS). Aim  To study the effects of fermented milk containing Bifidobacterium animalis DN‐173 010 and yoghurt strai...